FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treatment of Patients with Transthyretin Cardiomyopathy Pharmaceutical Investing
FDA Grants Breakthrough Therapy Designation to Lenti-D™ for the Treatment of Cerebral Adrenoleukodystrophy Genetics Investing
Merck’s KEYTRUDA Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment for Squamous Non-Small Cell Lung Cancer (NSCLC) in Pivotal Phase 3 KEYNOTE-407 Trial Pharmaceutical Investing
Kraig Biocraft Laboratories Develops New Breakthrough Spider Silk DNA Synthesis Protocols Accelerating Time to Market for New Products Biotech Investing
Takeda Announces Information Related to its Pending Voluntary and Conditional Public Takeover Bid for Outstanding Shares and American Depositary Shares of TiGenix Pharmaceutical Investing
VistaGen Therapeutics Receives Notice of Allowance of U.S. Patent for Treatment of Osteoarthritis and Joint Injuries with Stem Cell-Derived Chondrocytes and Cartilage Pharmaceutical Investing
Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy Genetics Investing
Microbot Medical Announces Receiving a Notification of Granting a Patent Right for its ViRob Technology Platform in China Medical Device Investing
